Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.
Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedA new 'Study Status' entry was added on 2026-01-13 and an entry from 2026-01-12 was removed in the record history.SummaryDifference0.2%
- Check13 days agoChange DetectedOn 2026-01-12, Eligibility and Study Status were added to the record history. A deletion occurred on 2025-12-17.SummaryDifference0.3%
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedVersion 3.3.3 updates the record to include full core content sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Study Status, Study Identification); a related IMvigor011 study reference was removed in a prior revision.SummaryDifference0.7%
- Check56 days agoChange DetectedRevision tag changed from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check63 days agoChange DetectedFooter revision labels show software version updates (v3.3.1 and v3.2.0) without changing study history data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check70 days agoChange DetectedRemoved the generic government funding/operating status notice from the page header. No trial data, statuses, or contact information were changed.SummaryDifference0.4%
Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.